Remote Chief Data Licensing & Commercial Strategy

Inovalon; United States; Remote; USD 180,000 - 280,000; Full time

Job summary

Inovalon is seeking a VP of Commercial Strategy to define how the Insights data business monetizes its assets across healthcare markets. You will shape enterprise licensing, align leaders across Sales, Legal, Finance, Product, Data Science, and Data Governance, and translate rights and governance into scalable commercial models.

You will drive pricing frameworks, structures, and partnerships, structure high-value enterprise licenses, oversee data collaborations, and ensure compliance with HIPAA

Qualifications

• 15+ years of experience in healthcare data and analytics, life sciences data, or other data-driven enterprise businesses, including 5 years in senior leadership in roles focused on data licensing, commercial contracting, or complex deal structuring.
• BA or BS degree in a business, legal, or technical discipline, or equivalent combination of education and experience required.
• Deep expertise in data licensing structures, including derived-data rights, permitted use, sublicensing terms, IP protections, and data partnership models.

Responsibilities

• Define and execute the commercial strategy for data licensing and derived-data partnerships across the Insights portfolio, including pricing frameworks, rights structures, permitted use models, and intellectual property protections.
• Lead the cross-functional coordination of data rights and licensing decisions with Sales, Legal, Finance, Product, Data Science, and Data Governance to support consistent, scalable commercial execution.
• Design licensing frameworks, templates, playbooks, approval guardrails, and fallback positions that reduce friction in negotiations and enable sellers to progress strategic deals without repeatedly revisiting core terms.
• Structure and support high-value enterprise licensing agreements, data partnerships, and other strategic commercial arrangements, including direct engagement in escalations, redlines, and resolution of non-standard terms.
• Ensure that commercial terms, licensing models, and deal structures remain aligned with underlying data rights, governance policies, third-party license obligations, and applicable regulatory requirements.
• Partner with Product, Data Science, and Data Governance to build monetization strategy and compliant licensing structures into new data products before they enter the market.
• Translate legal, regulatory, and governance constraints, including third-party data requirements, into commercially viable offerings that can be sold confidently across customer segments and use cases.
• Lead the commercial integration of data rights and contract structures in M&A activity, including harmonization of customer obligations, licensing terms, and acquired data asset considerations.
• Assess partnership and acquisition opportunities through a commercial data licensing lens, including contribution to valuation discussions where data assets are a primary driver of enterprise value.
• Monitor licensing performance, including deal velocity, non-standard term exceptions, and licensing-driven revenue, and present strategy, risk, and monetization recommendations to executive leadership.

Skills

Data licensing

Commercial strategy

Leadership

Healthcare data

Regulatory compliance

HIPAA knowledge

Pricing frameworks

M&A integration

Cross-functional leadership

Contracting negotiation

Education

Bachelor's degree in business, legal, or technical discipline

Master’s degree (MBA, JD, or similar)

Job description

Inovalon is seeking a VP of Commercial Strategy to define how the Insights data business monetizes its assets across healthcare markets. You will shape enterprise licensing, align leaders across Sales, Legal, Finance, Product, Data Science, and Data Governance, and translate rights and governance into scalable commercial models.

You will drive pricing frameworks, structures, and partnerships, structure high-value enterprise licenses, oversee data collaborations, and ensure compliance with HIPAA